News
Mologic and partners begin validation process for COVID-19 point-of-need diagnostic test
Mologic Ltd, a leading developer of lateral flow and rapid diagnostic technologies, announced that it has initiated early validation of COVID-19 point-of-need diagnostic tests with the Liverpool School of Tropical Medicine and St Georgeโs, University of London.
The availability of...
Drug Research
Cobra Biologics announces collaboration to develop Covid-19 DNA vaccine
Cobra Biologics and the Karolinska Institutet (KI) have been awarded โฌ3 million in emergency funding to take a DNA vaccine for Covid-19 through phase I clinical trial testing.
The funding, awarded by Horizon 2020, comes as part of the OPENCORONA...
Drug Research
Amidst Controversy, FDA Issues EUA Allowing Anti-Malaria Drugs to Be Used to Treat COVID-19
Only time will tell if any of the assays, medical equipment or drugs the U.S. FDA is approving for use during the COVID-19 pandemic under Emergency Use Authorization (EUA) will turn out to be ineffective or substandard. Now, the...
News
First-ever Dachser Mexico international charter airlifts over 3 million surgical masks to Germany
Dachser de Mรฉxico S.A. de C.V. (Dachser Mexico), a global logistics provider, announced that it provided air transportation of more than three million surgical and respiratory masks to Germany to help combat the spread of COVID-19. The fully loaded...
News
MedPharm Donates Hand Sanitizer for Healthcare Providers and Other Essential Workers
MedPharm, the leading global contract developer for topical pharmaceutical products, has quickly assembled resources in both the US and UK to produce and donate hand sanitizer to help fight the Covid-19 outbreak.
The speed of the Covid-19 pandemic has put...
Drug Research
J&J Identifies Lead COVID-19 Vaccine Candidate, Commits to Supply 1 Billion Vaccines Worldwide
Johnson & Johnson is moving forward with a vaccine candidate for COVID-19. The healthcare giant said it selected a lead vaccine candidate and plans to begin human testing in September, with first batches available under potential emergency use authorization...
News
Russian antitumor drugs first time received a registration certificate in Europe
Two BIOCAD products, Acellbia and Herticad , received the first European registration certificate in Bosnia and Herzegovina. Registration was received with the support of ICM d.o.o partner and is valid for 5 years. The first deliveries shall start in...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
















